POS-920 MORTALITY RATE OF COVID 19 IN END STAGE RENAL DISEASE WITH HEMODIALYSIS ROUTINE TREATMENT AT MARDI WALUYO HOSPITAL LAMPUNG INDONESIA, OCTOBER 2020-AUGUST 2021

Detalles Bibliográficos
Autores principales: ADITOMO, E., D/enny, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854876/
http://dx.doi.org/10.1016/j.ekir.2022.01.960
_version_ 1784653528840536064
author ADITOMO, E.
D/enny, D.
author_facet ADITOMO, E.
D/enny, D.
author_sort ADITOMO, E.
collection PubMed
description
format Online
Article
Text
id pubmed-8854876
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88548762022-02-18 POS-920 MORTALITY RATE OF COVID 19 IN END STAGE RENAL DISEASE WITH HEMODIALYSIS ROUTINE TREATMENT AT MARDI WALUYO HOSPITAL LAMPUNG INDONESIA, OCTOBER 2020-AUGUST 2021 ADITOMO, E. D/enny, D. Kidney Int Rep Article Published by Elsevier Inc. 2022-02 2022-02-18 /pmc/articles/PMC8854876/ http://dx.doi.org/10.1016/j.ekir.2022.01.960 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
ADITOMO, E.
D/enny, D.
POS-920 MORTALITY RATE OF COVID 19 IN END STAGE RENAL DISEASE WITH HEMODIALYSIS ROUTINE TREATMENT AT MARDI WALUYO HOSPITAL LAMPUNG INDONESIA, OCTOBER 2020-AUGUST 2021
title POS-920 MORTALITY RATE OF COVID 19 IN END STAGE RENAL DISEASE WITH HEMODIALYSIS ROUTINE TREATMENT AT MARDI WALUYO HOSPITAL LAMPUNG INDONESIA, OCTOBER 2020-AUGUST 2021
title_full POS-920 MORTALITY RATE OF COVID 19 IN END STAGE RENAL DISEASE WITH HEMODIALYSIS ROUTINE TREATMENT AT MARDI WALUYO HOSPITAL LAMPUNG INDONESIA, OCTOBER 2020-AUGUST 2021
title_fullStr POS-920 MORTALITY RATE OF COVID 19 IN END STAGE RENAL DISEASE WITH HEMODIALYSIS ROUTINE TREATMENT AT MARDI WALUYO HOSPITAL LAMPUNG INDONESIA, OCTOBER 2020-AUGUST 2021
title_full_unstemmed POS-920 MORTALITY RATE OF COVID 19 IN END STAGE RENAL DISEASE WITH HEMODIALYSIS ROUTINE TREATMENT AT MARDI WALUYO HOSPITAL LAMPUNG INDONESIA, OCTOBER 2020-AUGUST 2021
title_short POS-920 MORTALITY RATE OF COVID 19 IN END STAGE RENAL DISEASE WITH HEMODIALYSIS ROUTINE TREATMENT AT MARDI WALUYO HOSPITAL LAMPUNG INDONESIA, OCTOBER 2020-AUGUST 2021
title_sort pos-920 mortality rate of covid 19 in end stage renal disease with hemodialysis routine treatment at mardi waluyo hospital lampung indonesia, october 2020-august 2021
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854876/
http://dx.doi.org/10.1016/j.ekir.2022.01.960
work_keys_str_mv AT aditomoe pos920mortalityrateofcovid19inendstagerenaldiseasewithhemodialysisroutinetreatmentatmardiwaluyohospitallampungindonesiaoctober2020august2021
AT dennyd pos920mortalityrateofcovid19inendstagerenaldiseasewithhemodialysisroutinetreatmentatmardiwaluyohospitallampungindonesiaoctober2020august2021

Ejemplares similares